معرفی
Mason Marks is the Florida Bar Health Law Section Professor at Florida State University College of Law. He concurrently serves as Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at Harvard Law School's Petrie-Flom Center and is an Affiliated Fellow at Yale Law School's Information Society Project. Previously, he held fellowships at Harvard's Edmond J. Safra Center for Ethics and NYU's Information Law Institute.
His research examines drug policy, FDA regulation, artificial intelligence in healthcare, psychedelics law, and constitutional rights. Core interests include controlled substance regulation, AI's impact on medical decision-making, therapeutic applications of psychedelics, and freedom of thought protections under the First Amendment.
Publications demonstrate strong interdisciplinary focus across law, medicine, and technology. Recent work explores AI governance in healthcare, psychedelic therapy frameworks, constitutional drug decriminalization, and emergent medical data privacy. Articles frequently appear in top-tier law reviews (Harvard, Yale, Columbia) and medical journals (JAMA, NEJM, Nature).
Advises federal and state regulators including the FDA, NIH, and HHS on controlled substance policy and psychedelic therapy frameworks. Leads POPLAR's initiatives to develop evidence-based regulations for emerging psychedelic therapies.
Holds a J.D. from Vanderbilt Law School (2015), M.D. from Tufts University School of Medicine (2011), and B.A. from Amherst College (2000). Teaches Constitutional Law, Administrative Law, Drug Law, and seminars on technology and civil liberties.
